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Abstract
Background: We have recently reported the presence of the Human polyomavirus 7 (HPyV7) in human thymic
epithelial tumors as assessed by diverse molecular techniques. Here we report on the co-expression of p16,
retinoblastoma protein (pRb) and phosphorylated retinoblastoma protein (phospho-Rb) in human thymic epithelial
tumors in relation to HPyV7.
Methods: PRB, phospho-RB and p16 expression was assessed by immuno-histochemistry in 37 thymomas and 2
thymic carcinomas. 17 thymomas (46 %) and 1 thymic carcinoma (50 %) were recently tested positive for HPyV7. In
addition, 20 follicular hyperplasias were tested.
Results: Expression of pRb was observed in 35 thymomas (94.6 %), in 16 thymomas (43.2 %) the expression was
strong. Phospho-Rb was observed in 31 thymomas (83.8 %). 19 thymomas (51.4 %) showed immunoreactivity for p16
of which 8 thymomas revealed very strong p16 expression. No p16 expression was detected in thymic carcinomas. In
addition, no significant correlation between the presence of HPyV7 and pRb-, phospho-Rb- and p16-expression could
be established. No correlation between pRb, phospho-Rb, p16 and WHO staging, Masaoka-Koga staging or the
presence of MG was found. All 20 follicular hyperplasias showed expression of pRb and less expression of phospho-Rb.
Conclusions: Although polyomaviruses have been shown to interact with cell cycle proteins no correlation
between the presence of HPyV7 and the expression of pRb, phospho-Rb and p16 in human thymic epithelial
tumors was observed. In as much HPyV7 contributes to human thymomagenesis remains to be established.
Our data indicate pRb, phospho-Rb and p16 expression are rather unlikely to be involved in HPyV7 related
thymomagenesis.
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Background
Thymomas are rare tumors arising from thymic epithe-
lial cells. Frequently there is an association with
autoimmune diseases, most often (24.5–40 %) with
Myasthenia Gravis (MG) [1]. The aetiology of thymomas
is unknown though many studies focus on the role of
viruses testing diverse histological subtypes of thymic
epithelial tumors [1–3]. In mouse strains C3H/BiDa and
AKR the polyomavirus strain PTA induces thymomas,
[4, 5]. We have recently reported the presence of the
Human Polyomavirus 7 (HPyV7) in a large number of
human thymic epithelial tumors by fluorescence in situ
hybridization (FISH), immunohistochemistry (IHC) and
polymerase chain reaction (PCR). [6]. The human
polyomavirus 7 (HPyV7) was recently detected in
2010 from skin samples and prior to our report no
other human disease had been associated with the
presence of HPyV7 [7].
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Table 1 Summary of clinico–pathological data and results of thymomas
Clinicopathological data HPyV7 P16 ProteinRb
Lab ID G. Age MG Thym. type Masaoka–Koga Anti–AChR IS/Ster. IHC 2 t10 Anti–Rb phosRb
1–1 F 73 + B1/B2 I + + – – + +
1–2 F 75 + B1/B2 I + + – – + +
1–11 F 34 + B2 I + – – ++ + +
1–12 F 36 + A I – + – – – –
1–16 F 34 + A I + + – – + +
1–17 M 69 + AB I + + – (+) + +
1–18 F 47 + AB I + + – (+) (+) (+)
1–19 M 68 – AB I NA NA + + (+) (+)
1–21 F 38 + AB I + – – – + –
1–22 M 65 + AB/B2 I + – – ++ (+) (+)
1–28 M 38 – B1 I NA NA – (+) + +
1–31 F 82 + A I + + + – (+) –
1–32 M 47 + B2 I + – – (+) + +
1–34 M 59 – AB I NA NA + + + +
1–36 F 82 – AB I NA NA + + (+) (+)
1–39 F 78 – B1 I NA NA – + + +
1–43 F 78 – AB I NA NA (+) – + +
1–23 M 37 + AB IIA + – + (+) + +
1–24 M 68 + B2 IIA + – + (+) + +
1–33 F 43 + B2 IIA + – + – (+) +
1–35 M 45 + AB IIA + – + – + (+)
1–37 M 77 + AB IIA + – (+) (+) + +
1–38 F 80 + AB IIA + + – – – +
1–3 F 57 + B2/B3 IIB + – + – (+) (+)
1–5 M 37 + B3 IIB + + + – (+) (+)
1–7 F 79 + A IIB – – (+) – (+) (+)
1–8 M 58 + A/B2 IIB + – (+) (+) (+) –
1–9 M 64 – B2 IIB NA NA (+) – + (+)
1–15 F 53 + B3 IIB + + – ++ + +
1–26 M 65 – AB IIB NA NA – + + –
1–42 F 57 + AB IIB + – – + + +
1–10 F 73 + B3 III + + – – + +
1–13 F 54 – B2 III NA NA (+) + + +
1–20 M 64 – B3 III NA NA – – + –
1–41 M 65 – B3 III NA NA + (+) + +
1–4 M 40 + B2 IVA + + (+) – + (+)
1–30 M 37 + B2 IVA + + – – + +
17/37 19/37 35/37 31/37
46 % 51.4 % 94.6 % 83.8 %
Lab ID laboratory identification, G gender, MG myasthenia gravis, Thym. type thymoma type, anti–AChR anti–acetylcholine receptor antibodies,
IS/Ster immunosuppression/steroids, HPyV7 human polyomavirus 7, IHC immunohistochemistry using 2 t10 monoclonal antibody directed against
LTag of HPyV7, − negative, (+) weak positive, + positive, ++ strong positive expression, +++ very strong positive expression, NA not applicable
P16 expression – = < 1 %; (+) = 1 %; + = 1–25 %; ++ = > 25 %
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The human polyomavirus family is currently grow-
ing very fast [8–10], however, only the Merkel cell
polyomavirus (MCPyV) has yet been identified as a
novel human tumor virus in Merkel cell carcinomas
(MCC), which is a very aggressive skin cancer of eld-
erly and immune suppressed patients [11]. MCPyV is
found in more than 80 % of MCC’s and its DNA is
clonally integrated in the tumor genomes [11, 12]. In
addition, MCPyV harbours tumor specific mutations
of the large T antigen (LTag) [13]. MCPyV is sup-
posed to induces tumorgenesis via truncated large T
antigen (LTag) and small T antigen (STag) possibly
inhibiting the tumor suppressor protein retinoblast-
oma (pRb) and protein 53 (p53) [14–16]. It has been
demonstrated that the polyomavirus simian virus (SV
40) interacts through large T antigen in the cell cycle
by the binding of pRb and p53 [17]. Recently it has
been proposed that the LTag from WU polyomavirus,
human polyomavirus 6, HPyV7 and Malawi polyoma-
virus might interact with p53 and pRb [18, 19]. Hu-
man papilloma virus (HPV), another potent small
DNA tumorvirus is one of the most important viral
causes of human cancer, and shares with MCPyV a
homolog LxCXE motif in the encoded RB binding site
[13, 20]. Although HPV could not be related to thy-
momagenesis increased transcript expression of p16
(cyclin-dependent kinase inhibitor 2A) was reported
in human thymomas [21]. P16 is frequently used as a
surrogate marker for HPV infection in HPV related
cervical and oropharyngeal cancers [22]. Of interest,
only very limited data are available regarding the pos-
sible role of pRB and p16 in human thymomas [23,
24]. In the present study we aimed to analyse the ex-
pression of pRB and p16 in human thymic epithelial
tumors in relation to the presence of HPyV7.
Methods
Patients and tissue
Formalin-fixed and paraffin-embedded (FFPE) resection
specimens were included as previously described [6]. In
total 37 thymomas and 2 thymic carcinomas (19 females
and 18 males; mean age 58.3 years; range 34–82 years),
20 follicular hyperplasias (15 females, 5 males, and
mean age 27.4 years) of which 19 were diagnosed
with MG, were included in this study. Thymomas were
classified according to the world health organization
(WHO) classification in thymoma type A, type AB,
type B1, B2, B3 or thymic carcinoma [25]. The
Masaoka-Koga classification was used to define the
invasiveness of a thymoma [26]. Clinico-pathological
data of thymoma and thymic carcinoma patients are
summarized in Tables 1 and 2. All specimens were
obtained from the Maastricht Pathology Tissue Collection
(MPTC). All use of tissues and patient data was in agree-
ment with the Dutch Code of Conduct for Observational
Research with Personal Data (2004) and Tissue (2001,
www.fmwv.nl).
Immunohistochemistry
PRb and phosphoralized Rb (phospho-Rb) expression was
detected by using two monoclonal Retinoblastoma anti-
bodies: pRb (a.a. 332–344), clone G3-245, Pharmingen,
dilution 1:300 and phospho-Rb, clone D20B12, dilution
1:100. P16 expression was performed with a monoclo-
nal antibody (clone JC8, dilution 1:400) (Santa Cruz).
Secondary antibody detection and visualization were
done with the EnVision FLEX™ Kit K8008 (DAKO) or
K5005 (Dako) according to standard protocols. Expres-
sion levels were assessed and scored by three experi-
enced investigators (AzH, MAH, DR). The results of
the HPyV7 LTag expression using the 2 t10 antibody
have been described previously [6]. In the epithelial
cells of 17 thymomas (46 %) marked LTag expression
was found. The expression of LTag was in good agreement
with earlier performed HPyV7-DNA PCR and/or the
HPyV7-FISH [7].
Statistics
Statistical analysis was performed with SPSS 20.0 stat-
istical software (SPSS Inc., Chicago, IL, USA). Dichot-
omous variables are expressed as absolute numbers
and percentages (%) and were compared using the
chi-square test or Fisher’s exact test as appropriate.
The Spearman’s rank correlation was used in non-
parametric data to study the associations between dif-
ferent variables. Statistical significance was considered
with the probability value of P < 0.05.
Table 2 Summary of clinico–pathological data and results of thymic carcinomas
Clinicopathological data HPyV7 P16 ProteinRb
Lab ID G. Age MG Thym. type Masaoka–Koga Anti–AChR IS/Ster. IHC 2 t10 Anti–Rb phosRb
1–6 M 60 – C III N/A N/A (+) – + +
1–26 F 67 – C IVB N/A N/A – – + +
C thymic carcinoma, G gender, MG myasthenia gravis, anti–AChR anti–acetylcholine receptor antibodies, IS/Ster immunosuppression/steroids, NA not applicable,
HPyV7 human polyomavirus 7, IHC immunohistochemistry using 2 t10 monoclonal antibody directed against LTag of HPyV7, − negative, (+) weak positive,
+ positive, ++ strong positive expression
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Ethical approval
All specimens were collected at the Department of Path-
ology of the MaastrichtUniversity Medical Centre, for
the Maastricht Pathology Tissue Collection, which in-
cludes ethical approval.All use of tissue and patient data
was in agreement with the Dutch Code of Conduct for
ObservationalResearch with Personal Data (2004) and
Tissue (2001, www.fmwv.nl).
Results
Correlation between pRb and phosphorylated Rb
expression in human thymomas and thymic carcinomas
and HPyV7
Thirty-five thymomas (94.6 %) showed specific expres-
sion of pRb within the neoplastic epithelial thymic cells
(Fig. 1d). Phospho-Rb was observed in 31 thymomas
(83.8 %) within the same cell compartment as pRb
(Fig. 1c). No correlation between phospo-pRb expression
and presence of HPyV7 could be established. In
addition, no correlation was observed between the ex-
pression of pRb or phospho-Rb and WHO staging,
Masaoka-Koga staging or the presence of MG.
Correlation between HPyV7 and p16 expression in human
thymomas and thymic carcinomas
Nuclear and cytoplasmic p16 expression [27] was de-
tected in 19 thymomas (51.4 %) mainly within the
neoplastic epithelial cells but also in dendritic cells as
had been described [28]. Both thymic carcinomas did
not reveal any p16 expression. No correlation between
the immunoreactivity of p16 and WHO staging,
Masaoka-Koga staging or the presence of MG was estab-
lished. Of the 17 patients positive for large LTag, 9 pa-
tients (52.9 %) showed expression of p16. However, p16
was also detected in 10 patients (50 %) negative for LTag
(Table 3). Three patients (8.1 %) showed very strong ex-
pression of p16 (++) (Fig. 1b). No differences regarding
p16 expression levels were observed between LTag posi-
tive and negative thymomas. Therefore, the presence of
HPyV7 was not associated with p16 expression.
Fig. 1 20X magnification images of thymoma 1–15 (Table 1). Upper left: Hematoxylin and eosin (H.E.) staining of a B3 thymoma revealing only
few intraepithelial lymphocytes; upper right:immunohistochemical staining confirms strong (++) nuclear and cytoplasmatic expression of p16 (red
color); lower left: expression of phospho-Rb is restricted to the nucleus of the thymic epithelial cells (brown color); lower right: expression of spe-
cific pRb is also restricted to the nucleus of the thymic epithelial cells (brown)
Table 3 Absence of a correlation between P16 and HPyV7 in
early and late stage thymoma and thymic carcinoma
HPyV7 IHC 2 t10
Masaoka– Koga I or II Masaoka–Koga III or IV
– + – +
P16
– 6 8 5 1
+ 10 7 0 2
Double positive 15/31 2/8
48.4 % 25.0 %
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Follicular hyperplasia
PRb was detected in all 20 follicular hyperplasias in the
lymphocytes. Phospho-Rb was also expressed in the lym-
phocytes in all follicular hyperplasias however, with a
much lower intensity.
Discussion
The presence of HPyV7 and the expression of the viral
LTag were detected in the epithelial cells of human
thymic epithelial tumors by PCR, FISH and IHC [6].
Yet, no information concerning the oncogenic cap-
acity of HPyV7 is available. Of the 12 known human
polyomaviruses only MCPyV has proven oncogenic
capacity [11]. Expression of p16 has been detected in
human thymic epithelial tumors on the transcriptional
and translational level [21, 23, 24]. Since expression
of p16 has been proposed as a potential surrogate
marker for the presence and involvement of tumor vi-
ruses e.g., HPV, we investigated in as much p16 ex-
pression in human thymic epithelial tumors correlate
with the presence of HPyV7 or expression of its LTag.
However, we detected no correlation between the ex-
pression of LTag and p16 in human thymic epithelial
tumors. Next, we investigated the co-expression of
pRb/phospho-Rb and LTag because pRb is a major
G1 checkpoint, which blocks S-phase entry and cell
growth. However, no correlation between the immu-
noreactivty of pRB and/or phospho-Rb and LTag was
observed.
Interestingly, we did not detect a specific pattern
of p16 or pRB expression in relation to the invasive-
ness of thymomas. In our study 17/31 (54.8 %) of
Masaoka-Koga Stage I or II and 2/8 (25 %) of
Masaoka-Koga stage III or IV thymic epithelial tu-
mors were double positive for P16 and pRb. This is
in contrast with Hirabayashi et al. who reported that
inactivation of p16 or RB could play a role in the
progression of thymomas [23]. These differences are
most likely a result of a distinct classification of
non-invasive and invasive thymomas e.g., Masaoka
stage II was counted as non-invasive in our study
because of the little difference in overall survival be-
tween stage I and II [29]. More recently, Omatsu et
al. showed that increasing malignancy is molecularly
paralleled by a stepwise increase of p16 expression
[24]. However, the difference within expression of
p16 was only shown between thymic carcinomas and
thymomas, without differences in expression level
within thymomas. In our series only two thymic car-
cinomas were included and they were both negative
for p16 expression. Interestingly, there were 3 pa-
tients (8.1 %) with strong immunoreactivity of p16
(++), none of these patients showed expression of
LTag of HPyV7. As HPV infection has been ruled
out as a possible cause for this p16 overexpression
[21] these findings might suggest a role in virology.
Diverse human viruses including Poliovirus and
oncogenic γ-herpesvirus Epstein Barr Virus have been
detected in human thymic epithelial tumors [1, 2] on
the search for the role of viruses in the pathogenesis
of MG. Yet, these results need to be confirmed in a
larger number of thymic epithelial tumors
Conclusions
In conclusion, in this study we found no correlation be-
tween the presence of HPyV7 and pRb, phospho-Rb and
p16 in human thymic epithelial tumors.
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